Arix Bioscience PLC said CEO Joe Anderson will become the chief investment officer.

The company added that Anderson will also step down from the board, effective Sept. 4.

Executive Chairman Jonathan Peacock will assume corporate and operating responsibilities and will work with the board to recruit a new CEO.

London-based Arix is an investment company that invests in medical innovation comprising healthcare and the life sciences.